Scrapie
Scrapie is a fatal, degenerative disease that affects the nervous systems of sheep and goats. It is one of several Transmissible spongiform encephalopathies (TSEs), which are related to Bovine spongiform encephalopathy (BSE, or "mad cow disease") and Creutzfeldt–Jakob disease (CJD) in humans.
History[edit]
Scrapie has been known since 1732, and does not appear to be transmissible to humans. The name "scrapie" is derived from the Norwegian word skraper, which means "to scrape". It was first scientifically described in 1938.
Symptoms[edit]
Scrapie is characterised by itching and rubbing against fixed objects, caused by damage to the nervous system. Other symptoms include weight loss despite retention of appetite, abnormal behaviour, tremors, and changes in gait.
Transmission[edit]
Scrapie is believed to be caused by a type of protein known as a prion. Prions are able to reproduce by converting normal proteins into the disease-associated form. Scrapie is transmitted primarily through the ingestion of placenta or placental fluids from infected animals.
Diagnosis[edit]
Scrapie can be diagnosed by examining the brain tissue of deceased animals. A test known as the Western blot can be used to detect the presence of the abnormal prion protein.
Treatment and control[edit]
There is currently no cure for scrapie. Control measures include selective breeding for resistance to the disease, and the culling of infected animals.
See also[edit]
- Prion
- Transmissible spongiform encephalopathies
- Bovine spongiform encephalopathy
- Creutzfeldt–Jakob disease
-
Scrapie
-
Scrapie
-
UK Open Government Licence
-
Prion subdomain colored secondary structure
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
